Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombopoietin Receptor Agonist”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01147809
What this trial is testing

Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 130
Not applicableUnknownNCT06568913
What this trial is testing

The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids

Who this might be right for
Persistent or Chronic ITP Not Respnding to Steroids
Sohag University 100
Not applicableLooking for participantsNCT05931718
What this trial is testing

Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia

Who this might be right for
Autoimmune Hemolytic AnemiaImmune ThrombocytopeniaChronic Idiopathic Neutropenia+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 200
Testing effectiveness (Phase 2)Looking for participantsNCT07586826
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGynecologic Cancers+7 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)UnknownNCT05369377
What this trial is testing

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01328587
What this trial is testing

Eltrombopag for Moderate Aplastic Anemia

Who this might be right for
Moderate Aplastic AnemiaUnilineage Bone Marrow Failure Disorders
National Heart, Lung, and Blood Institute (NHLBI) 34
Post-approval studies (Phase 4)Study completedNCT00888901
What this trial is testing

Platelet Function in Idiopathic Thrombocytopenic Purpura (ITP) Patients With Eltrombopag

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Ingrid Pabinger, MD 30
Early research (Phase 1)Study completedNCT01481220
What this trial is testing

Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromeThrombocytopenia
Nordic MDS Group 12
Testing effectiveness (Phase 2)Looking for participantsNCT06693791
What this trial is testing

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 34
Large-scale testing (Phase 3)Study completedNCT05220878
What this trial is testing

Comparative Study of Clinical Efficacy and Safety of GNR-069 and Nplate in Patients With ITP

Who this might be right for
Idiopathic Thrombocytopenic Purpura
AO GENERIUM 160
Large-scale testing (Phase 3)Study completedNCT01520909
What this trial is testing

Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
GlaxoSmithKline 92